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Abstract
Background: The enzyme cytochrome P450 aromatase, catalysing the conversion of androgens
into estrogens, has been detected in normal human testicular cells suggesting a physiological role
of local estrogen biosynthesis on spermatogenesis control. Estrogens, regulating cell growth and
apoptosis, can also be involved in tumorigenesis process, but the possible link between estrogens
and testicular neoplastic process is, up to now, scarcely known. This study examined aromatase
expression in human seminoma, which is the most common germ cell tumour of the testis.
Methods: The tumour-bearing testes were obtained from 20 patients with classic seminoma
undergoing to therapeutic orchidectomy. Paraffin embedded tissues were processed for
immunohistochemistry using a mouse monoclonal antibody generated against human placental
cytochrome P450 arom, as primary antibody, and a biotinylated goat-anti-mouse IgG, as secondary
antibody. Furthermore, Western blot analysis of seminoma extracts was carried out.
Results: Intense P450 arom immunoreactivity was observed in the seminoma cells and Western
blot analysis confirmed the immunodetection. A strong immunostaining was also detected in cells
of intratubular germ cell neoplasia (IGCN), adjacent to seminoma.
Conclusion: The present study demonstrated, for the first time in human, aromatase expression
in neoplastic cells of seminoma suggesting a relation between local estrogen biosynthesis and germ
cell tumorigenesis. The P450 arom immunolocalization in the cells of IGCN, representing the
common precursor of most germ cell tumors, seems to support these findings.
Background
Somatic and germ cell tumors are typical testicular neo-
plasms which can affect young, adult and elderly men. In
the last years, testis tumor management has improved by
new diagnostic and surgical tools, as well as by innovative
therapy options to preserve fertility against cytotoxic treat-
ments [1]. However, pathogenesis of male gonad malig-
nancies is often still unknown.
Somatic and germ cells of normal human testis have
revealed the expression of estrogens receptor-β and /or
aromatase, which is the microsomial enzyme catalysing
the conversion of androgens into estrogens [2-8]. There-
fore, testicular cells are considered targets and in situ bio-
synthesis sites of estrogens, suggesting a physiological role
of these hormones in steroidogenesis control and sperm
maturation.
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Estrogens are also known to regulate cell growth and
apoptosis, therefore they can be involved in tumorigene-
sis process [9,10] but, up to now, their possible link with
testicular neoplastic process is scarcely known.
Germ cell tumors, comprising seminoma and non-semi-
noma, are the most common malignancies among
human male aged 15–40 years. Aim of this work was to
investigate aromatase expression in seminoma which rep-
resents approximatively the 40% of these testicular neo-
plasms.
Methods
Samples and histopathological studies
The archival cases (collected during the last 3 years) were
provided by the Pathologic Anatomy Unit (Annunziata
Hospital). Tumoral testicular tissues were obtained from
20 patients (ages from 27 to 38 years) with unilateral clas-
sic seminoma undergoing to therapeutic orchidectomy.
Normal testicular tissues were obtained from 2 patients
showing testes with a granulomatous lesion. The ethical
committee members of the University of Calabria
approved the investigation programme.
Tissues were fixed in formalin (4%), dehydrated with a
series of ethanol solutions and paraffin-embedded. Paraf-
fin sections, 5 µm thick, were mounted on slides pre-
coated with polylysine, deparaffinized and rehydrated (7–
8 serial sections for each sample). These sections were
used for morphological and immunohistochemical anal-
yses.
Histopathological studies were carried out by Haematox-
ylin-Eosin staining. Seminoma samples were also investi-
gated by placental-like alkaline phosphatase (PLAP)
immunohistochemistry (monoclonal mouse anti human
PLAP, clone 8A9, DAKO-Cytomation, Milan, Italy)
Furthermore, 50 µm thick [11] paraffin serial sections of
seminoma specimens were cut for protein extraction and
mounted on glass slides.
P450 arom immunohistochemistry
Immunohistochemistry was performed after heat-medi-
ated antigen retrieval [12]. Hydrogen peroxide (3% in dis-
tillate water) was used, for 30 minutes, to inhibit
endogenous peroxidase activity while normal goat serum
(10%) was utilised, for 30 minutes, to block the non-spe-
cific binding sites. P450 arom immunodetection was car-
ried out using a monoclonal mouse anti-human
cytochrome P450 aromatase (MCA 2077, Serotec,
Oxford,UK) (1:50 in TBS) at 4°C overnight. Then, a bioti-
nylated horse-anti-mouse IgG (Vector Laboratories, CA,
USA) was applied (1:600 in TBS) for 1 hour at RT, fol-
lowed by the avidin-biotin-horseradish peroxidase com-
plex (ABC/HRP) (Vector, Laboratories, CA, USA).
Immunoreactivity was visualized by using the diami-
nobenzidine chromogen (DAB) (Zymed Laboratories,
CA, USA) and, finally, sections were counterstained with
haematoxylin. The primary antibody was replaced by nor-
mal rabbit serum in negative control, while the absorp-
tion control has utilised a primary antibody preabsorbed
with an excess (5 nmol/ml) of purified human placental
aromatase protein (4°C for 48 hours). Rat ovary sections
were used as positive control. 6–7 serial sections were
processed for each sample.
Protein extraction
Protein extraction from formalin-fixed paraffin-embed-
ded sections has been carried out according to Ikeda [11].
Briefly, 50 µm testis sections from seminoma regions were
deparaffinized in xylene, reydrated in graded ethanol,
immersed in distilled water, and air dried. Then, the neo-
plastic area was recovered from the glass slides, further it
was cut into small pieces and placed in Eppendorf tubes.
Two hundred µl of RIPA buffer, pH 7,6 (1 M NaH2PO4, 10
mM Na2HPO4,154 mM NaCl, 1% Triton X-100, 12 mM
C24H39O4Na, 0.2% NaN3, 0.95 mM NaF, 2 mM PMSF, 50
mg/ml aprotinin, 50 mM leupeptin) (Sigma Chemical,
Saint Louis, MO,USA) containing 0.2% SDS, was added to
each tube and the contents were incubated at 100°C for
20 minutes, followed by incubation at 60°C for 2 hours.
After incubation, tissue lysates were centrifuged at 15.000
× g for 20 minutes at 4°C and the supernatants were
stored at -80°C until biochemical analysis.
Western blot analysis
Tissue lysates were quantified using Bradford protein
assay reagent [13]. Equal amounts of protein (50 µg) were
boiled for 5 minutes, separated under denaturing condi-
tions by SDS-PAGE on 10% polyacrylamide Tris-glycine
gels and electroblotted to nitrocellulose membrane. Non-
specific sites were blocked with 5% non fat dry milk in
0.2% Tween-20 in Tris-buffered saline (TBS-T) for 1 hour
at room temperature and then probed with a rabbit poly-
clonal antiserum generated against human P450 aro-
matase(Hauptman-Woodward Medical Research
Institute, Buffalo, NY, USA) (1:750). After extensive wash-
ings (three times for 15 minutes each time in TBS-T), a
goat-antirabbit (1:7000) horseradish peroxidase-conju-
gated antibody (Vector Laboratories, CA, USA) was added
for 1 hour at 22°C. Blots were again washed three times
for 15 minutes in TBS-T and the bound of secondary anti-
body was located with the ECL Plus Western blotting
detection system according to the manufacturer's instruc-
tions. Each membrane was exposed to the film for 2 min-
utes. P450 arom protein, isolated from human placenta,
was used as positive control. Negative control was pre-
pared using tissue lysate, where P450 arom was previously
removed by preincubation with P450 arom antibody (1Reproductive Biology and Endocrinology 2005, 3:72 http://www.rbej.com/content/3/1/72
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hour at room temperature) and subsequently immuno-
precipitated with protein A/G – agarose.
Results
Histopathological study
Tumoral regions of all specimens have revealed the pres-
ence of classic seminoma with a uniform population of
large neoplastic cells and extensive leukocytic infiltration
(Fig 1A,B). All seminoma specimens showed tumor stage
I.
The region adjacent to seminoma (60% of samples) has
shown the presence of abnormal seminiferous tubules
with decreased tubular diameters and lacking sperma-
togenesis, which were identified as intratubular germ cell
neoplasia (IGCN). These intratubular lesions were charac-
terised by the basal proliferation of undifferentiated atyp-
ical enlarged germ cells, with big nuclei, and by the
presence of Sertoli cells in luminal displacement.
The IGCN diagnosis was confirmed by PLAP immunohis-
tochemistry. In fact, cytoplasmic and membranous dark
staining have revealed the PLAP immunopositivity in the
malignant cells aligned along the basal portion of sem-
iniferous tubules (Fig 2B), indicating their germ cell ori-
gin.
Morphology and P450 arom immunoreactivity of tumoral region in human testis with seminoma Figure 1
Morphology and P450 arom immunoreactivity of tumoral region in human testis with seminoma. A-B: Haematoxylin-eosin 
staining. C-D: Strong P450 arom immunoreactivity in cytoplasm of neoplastic cells (Nc) and unstained lymphocytes (L). Insert: 
absorption control. Scale bars: A, 20 µm; B-C, 12.5 µm; D, 5 µm.Reproductive Biology and Endocrinology 2005, 3:72 http://www.rbej.com/content/3/1/72
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Furthermore, normal testes have displayed typical normal
seminiferous tubules, with active spermatogenesis.
P450 arom immunolocalization
P450 arom immunoreactivity in testicular cells was
detected as cytoplasm staining while the nuclei were
immunonegative.
In tumoral regions, neoplastic cell cords have revealed a
strong immunoreactivity, while the surrounding abun-
dant lymphocytes and connective cells were all immu-
nonegative. The immunostaining pattern was similar in
all the 20 examined samples and pictures in the figures
show representative specimens (Fig 1C,D). In all the 12
testis samples with intratubular germ cell neoplasia, an
intense immunostaining has been observed in the cells of
IGCN, adjacent to seminoma, either in the abnormal
germ cells or in Sertoli cells (Fig 2A). Leydig cells, clus-
tered in interstitial tissue among IGCN, were strongly
immunoreactive, representing an internal positive control
(data not shown). Furthermore, the 2 normal testes have
revealed an intense immunoreactivity in Leydig cells,
while tubular compartments were all completely immu-
nonegative (Fig 2C).
Negative (data not shown) and absorption controls
(insert of figure 1C) were all immunonegative. As
expected, ovarian tissue has shown a strong immunoreac-
tivity in luteal cells (positive control) (Fig 2D).
Western blot analysis
Lysates of all the 20 formalin-fixed paraffin-embedded
testis sections from seminoma tumoral regions have been
submitted to Western blot analysis. All specimens have
shown a single band corresponding to a molecular mass
of 55 kDa, which is the correct size of human P450 arom
protein (3 representative samples are shown in Fig 3). The
band migrated at the same mobility as purified human
placental P450 arom protein which was used as positive
control, while the immunoreactive P450 arom band was
lacking in the negative control (Fig 3)
Discussion
The present study has demonstrated, for the first time,
aromatase expression in neoplastic cells of human semi-
noma, which is the most common testicular germ cell
tumor of men in reproductive age.
Aromatase detection in Leydig cells, Sertoli cells and elon-
gated spermatids of normal human testis has suggested
the involvement of local estrogen production in gonadal
physiology [3,4,7]. At the same time, the mitogenic estro-
gen action could be related to the testicular tumor etiol-
ogy, as hypothesized for human breast, ovarian,
endometrial and epathic malignancies [14,15].
Epidemiological studies have indicated a higher incidence
of testicular cancers after prenatal estrogen exposure [16-
19]. Furthermore, a link between exposure to estrogens/
estrogen mimics and testicular cancer risk has been
hypothesized [20,21].
Few studies have investigated aromatase in testicular
tumors. Among somatic testis tumors, a large cell calcify-
Immunoblot of aromatase from seminoma extracts Figure 3
Immunoblot of aromatase from seminoma extracts. Lane 1: 
purified P450 arom protein from human placenta (positive 
control). Lane 2: negative control prepared as described in 
Material and Methods. Lanes 3, 4, 5: 55 kDa P450 arom 
immunoreactive bands from lysates of three different semi-
noma extracts. Numbers on the left correspond to molecular 
weights of marker proteins.
P450 arom immunoreactivity in testicular region adjacent to  seminoma and in controls A: Intense aromatase immunos- taining in IGCN cells Figure 2
P450 arom immunoreactivity in testicular region adjacent to 
seminoma and in controls A: Intense aromatase immunos-
taining in IGCN cells. B: Placental-like alkaline phosphatase 
staining of IGCN basal cells C: Strong aromatase immunore-
activity of interstitial Leydig cells in normal testis (Lc) D: 
Intense immunostaining of luteal cells (Luc) in ovarian tissue 
Scale bars: A-B, 8 µm; C,12.5 µm; D, 5 µm.Reproductive Biology and Endocrinology 2005, 3:72 http://www.rbej.com/content/3/1/72
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ing Sertoli cell tumor [22] and Sertoli cell tumors of Peutz-
Jeghers syndrome have shown an enhanced expression of
this enzyme [23,24]. Furthermore, the single Nakazumi's
report on testicular germ cell tumors has not detected aro-
matase expression in neoplastic cells of seminomas and
non-seminomas but it revealed the enzyme presence only
in stromal cells of non seminomas [25].
The present study has shown aromatase immunolocaliza-
tion in seminoma cells and Western blot analysis has con-
firmed this result. Our data disagree with Nakazumi's
reports, but probably, the recent antibodies, used in our
investigation, have improved aromatase immunodetec-
tion. In addition, our findings agree to a very recent work
demonstrating the aromatase expression in human testic-
ular seminoma cell line, JKT-1 [26].
Furthermore, a strong P450 arom immunoreactivity has
been observed inside the abnormal tubules of IGCN,
which represents the common precursor of most germ cell
tumours. Invasion of the tubular wall by malignant germ
cells or intratubular proliferation of tumour cells are the
two theories proposed to understand the switch from
IGCN to testicular neoplasia [27,28]. However, to date,
the mechanisms of invasive tumour development from
pre- invasive lesion are still to be elucidated. P450 arom
presence in malignant germ cells and in Sertoli cells of
IGCN is a new finding which supports aromatase expres-
sion during seminoma development and suggests a possi-
ble role of local estrogen biosynthesis in tumorigenesis
process. The aromatase absence in germ and Sertoli cells
inside seminiferous tubules of normal testes supports this
hypothesis. Concerning normal testes, aromatase detec-
tion in Leydig cells agrees with previous reports [3,7], but
its absence in seminiferous tubule cells could disagree
with Turner's paper [7] indicating a "possible" P450 arom
expression in elongated spermatids and a "faint immuno-
positive reaction in Sertoli cells". However, the same
authors claimed the immunostaining "less convincingly
specific in human" than in marmoset and rat.
Conclusion
Finally, the present study is the first report of aromatase
expression in human testicular germ cells after malignant
transformation, indicating that estrogens, from in situ
aromatization, could act as autocrine mitogenic factors
promoting neoplastic growth. These findings could repre-
sent a cue for further studies on estrogen involvement in
testicular germ cell tumorigenesis and new pharmacolog-
ical treatment.
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